CD8A and neoplasm: This interaction forms a physical “tumor immune barrier” at the tumor boundary, which restricts the infiltration of cytotoxic CD8+ T cells into the tumor core, thereby creating an immune-excluded phenotype and contributing to resistance against immune checkpoint blockade therapy (26).